The excitatory amino acid antagonist d-CPP-ene (SDZ EAA-494) in patients with epilepsy
- 31 October 1993
- journal article
- case report
- Published by Elsevier in Epilepsy Research
- Vol. 16 (2), 165-174
- https://doi.org/10.1016/0920-1211(93)90031-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Dystonia induced by combined treatment with L‐dopa and MK‐801 in parkinsonian monkeysAnnals of Neurology, 1992
- Responses to NMDA receptor antagonists altered by epileptogenesisTrends in Pharmacological Sciences, 1991
- Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primateMovement Disorders, 1991
- Anticonvulsant activity of the NMDA antagonists, d(−)4-(3-phosphonopropyl)piperazine-2-carboxylic acid (D-CPP) and d(−)(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsyEpilepsy Research, 1990
- Potent oral anticonvulsant action of CPP and CPPene in DBA/2 miceEuropean Journal of Pharmacology, 1990
- Dyskinesia in the primate following injection of an excitatory amino acid antagonist into the medial segment of the globus pallidusBrain Research, 1989
- Seizure-like discharges induced by lowering [Mg2+]0 in the human epileptogenic neocortex maintained in vitroBrain Research, 1987
- Antiepileptic action of excitatory amino acid antagonists in the photosensitive baboon, papio papioNeuroscience Letters, 1983
- Anticonvulsant Action of Excitatory Amino Acid AntagonistsScience, 1982
- Selective factors in memory. Part 2: affective disorderPsychological Medicine, 1972